ArticleIntractable & rare diseases research2025

Vimseltinib: A novel colony stimulating factor 1 receptor (CSF1R) inhibitor approved for treatment of tenosynovial giant cell tumors (TGCTs).

Fangzhou Dou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.